Cargando…

Impact of the Medicare hospital readmissions reduction program on vulnerable populations

BACKGROUND: The Hospital Readmissions Reduction Program (HRRP) was established by the 2010 Patient Protection and Affordable Care Act (ACA) in an effort to reduce excess hospital readmissions, lower health care costs, and improve patient safety and outcomes. Although studies have examined the policy...

Descripción completa

Detalles Bibliográficos
Autores principales: Gai, Yunwei, Pachamanova, Dessislava
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857270/
https://www.ncbi.nlm.nih.gov/pubmed/31727168
http://dx.doi.org/10.1186/s12913-019-4645-5
_version_ 1783470732951420928
author Gai, Yunwei
Pachamanova, Dessislava
author_facet Gai, Yunwei
Pachamanova, Dessislava
author_sort Gai, Yunwei
collection PubMed
description BACKGROUND: The Hospital Readmissions Reduction Program (HRRP) was established by the 2010 Patient Protection and Affordable Care Act (ACA) in an effort to reduce excess hospital readmissions, lower health care costs, and improve patient safety and outcomes. Although studies have examined the policy’s overall impacts and differences by hospital types, research is limited on its effects for different types of vulnerable populations. The aim of this study was to analyze the impact of the HRRP on readmissions for three targeted conditions (acute myocardial infarction, heart failure, and pneumonia) among four types of vulnerable populations, including low-income patients, patients served by hospitals that serve a high percentage of low-income or Medicaid patients, and high-risk patients at the highest quartile of the Elixhauser comorbidity index score. METHODS: Data on patient and hospital information came from the Nationwide Readmission Database (NRD), which contained all discharges from community hospitals in 27 states during 2010–2014. Using difference-in-difference (DD) models, linear probability regressions were conducted for the entire sample and sub-samples of patients and hospitals in order to isolate the effect of the HRRP on vulnerable populations. Multiple combinations of treatment and control groups and triple difference (DDD) methods were used for testing the robustness of the results. All models controlled for the patient and hospital characteristics. RESULTS: There have been statistically significant reductions in readmission rates overall as well as for vulnerable populations, especially for acute myocardial infarction patients in hospitals serving the largest percentage of low-income patients and high-risk patients. There is also evidence of spillover effects for non-targeted conditions among Medicare patients compared to privately insured patients. CONCLUSIONS: The HRRP appears to have created the right incentives for reducing readmissions not only overall but also for vulnerable populations, accruing societal benefits in addition to previously found reductions in costs. As the reduction in the rate of readmissions is not consistent across patient and hospital groups, there could be benefits to adjusting the policy according to the socioeconomic status of a hospital’s patients and neighborhood.
format Online
Article
Text
id pubmed-6857270
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68572702019-12-05 Impact of the Medicare hospital readmissions reduction program on vulnerable populations Gai, Yunwei Pachamanova, Dessislava BMC Health Serv Res Research Article BACKGROUND: The Hospital Readmissions Reduction Program (HRRP) was established by the 2010 Patient Protection and Affordable Care Act (ACA) in an effort to reduce excess hospital readmissions, lower health care costs, and improve patient safety and outcomes. Although studies have examined the policy’s overall impacts and differences by hospital types, research is limited on its effects for different types of vulnerable populations. The aim of this study was to analyze the impact of the HRRP on readmissions for three targeted conditions (acute myocardial infarction, heart failure, and pneumonia) among four types of vulnerable populations, including low-income patients, patients served by hospitals that serve a high percentage of low-income or Medicaid patients, and high-risk patients at the highest quartile of the Elixhauser comorbidity index score. METHODS: Data on patient and hospital information came from the Nationwide Readmission Database (NRD), which contained all discharges from community hospitals in 27 states during 2010–2014. Using difference-in-difference (DD) models, linear probability regressions were conducted for the entire sample and sub-samples of patients and hospitals in order to isolate the effect of the HRRP on vulnerable populations. Multiple combinations of treatment and control groups and triple difference (DDD) methods were used for testing the robustness of the results. All models controlled for the patient and hospital characteristics. RESULTS: There have been statistically significant reductions in readmission rates overall as well as for vulnerable populations, especially for acute myocardial infarction patients in hospitals serving the largest percentage of low-income patients and high-risk patients. There is also evidence of spillover effects for non-targeted conditions among Medicare patients compared to privately insured patients. CONCLUSIONS: The HRRP appears to have created the right incentives for reducing readmissions not only overall but also for vulnerable populations, accruing societal benefits in addition to previously found reductions in costs. As the reduction in the rate of readmissions is not consistent across patient and hospital groups, there could be benefits to adjusting the policy according to the socioeconomic status of a hospital’s patients and neighborhood. BioMed Central 2019-11-14 /pmc/articles/PMC6857270/ /pubmed/31727168 http://dx.doi.org/10.1186/s12913-019-4645-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Gai, Yunwei
Pachamanova, Dessislava
Impact of the Medicare hospital readmissions reduction program on vulnerable populations
title Impact of the Medicare hospital readmissions reduction program on vulnerable populations
title_full Impact of the Medicare hospital readmissions reduction program on vulnerable populations
title_fullStr Impact of the Medicare hospital readmissions reduction program on vulnerable populations
title_full_unstemmed Impact of the Medicare hospital readmissions reduction program on vulnerable populations
title_short Impact of the Medicare hospital readmissions reduction program on vulnerable populations
title_sort impact of the medicare hospital readmissions reduction program on vulnerable populations
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857270/
https://www.ncbi.nlm.nih.gov/pubmed/31727168
http://dx.doi.org/10.1186/s12913-019-4645-5
work_keys_str_mv AT gaiyunwei impactofthemedicarehospitalreadmissionsreductionprogramonvulnerablepopulations
AT pachamanovadessislava impactofthemedicarehospitalreadmissionsreductionprogramonvulnerablepopulations